Skip Navigation
 
 
 
 
Headache Institute

Geisinger's Neurosciences Institute provides specialized treatment for headaches not found at most headache centers nationwide. Our fellowship-trained specialists offer treatment options for a wide variety of headaches, including:

  • New daily persistent headache
  • Refractory migraine headache
  • Cluster headache and other trigeminal autonomic cephalalgias
  • Chronic daily headache
  • Atypical headache
  • Post-procedural headaches

The Headache Institute at Geisinger Wyoming Valley offers headache infusion therapy, a unique outpatient treatment strategy for headache patients. Some patients will only use the infusion center one time while others will use it intermittently to maintain control of their headaches. Headache infusion uses Intravenous medications, given for a set period of time per day for up to three days in a row.

The goal of infusion therapy is to:

  • Reduce headache intensity and frequency
  • Help patients get out of medication rebound headache by providing treatment at the same time they stop their overused medications
  • Discover what medications with what mechanisms of action will help that individual's headaches. This provides the headache specialist important information to create a more effective acute headache and preventive treatment program.

Candidates for Headache Infusion Therapy include:

  • Chronic daily headache patients without medication overuse who have failed multiple preventive and abortive agents and who are disabled by their headaches but do not require or want inpatient treatment
  • Chronic daily headache patients with medication overuse who can be detoxified safely from daily "rebounding medication" as an outpatient without risk of withdrawal. This would include patients taking daily triptans, over the counter agents, low dose butalbital and those on a non-daily use of opiates
  • Patient with frequent but not daily headaches who are frustrated by their lack of response to medications
  • Migraine headache lasting more than 24 hours and not responding to typical medications (status migraine)
  • Patients experiencing a prolonged aura
  • Cluster headache exacerbation
  • New daily persistent headache

For more information or to refer a patient, call MedLink, Geisinger's physician referral line, at 1.800.332.8901.